Biology of Blood and Marrow Transplantation
Volume 14, Issue 1 , Pages 28-35 , January 2008

A Prognostic Score for Patients with Acute Leukemia or Myelodysplastic Syndromes Undergoing Allogeneic Stem Cell Transplantation

  • Philippe Armand

      Affiliations

    • Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts
    • Corresponding Author InformationCorrespondence and reprint requests: Philippe Armand, MD, PhD, Dana-Farber Cancer Institute, 44 Binney Street, Boston MA 02115.
  • ,
  • Haesook T. Kim

      Affiliations

    • Department of Biostatistics, Dana-Farber Cancer Institute, Boston, Massachusetts
  • ,
  • Corey S. Cutler

      Affiliations

    • Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts
  • ,
  • Vincent T. Ho

      Affiliations

    • Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts
  • ,
  • John Koreth

      Affiliations

    • Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts
  • ,
  • Jerome Ritz

      Affiliations

    • Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts
  • ,
  • Edwin P. Alyea

      Affiliations

    • Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts
  • ,
  • Joseph H. Antin

      Affiliations

    • Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts
  • ,
  • Robert J. Soiffer

      Affiliations

    • Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts

Received 14 September 2006 ,Accepted 12 July 2007.

  • Image Result

    OS of patients stratified by risk score. A, Training set; B, validation set.

    OS of patients stratified by risk score. A, Training set; B, validation set.

  • Image Result

    Outcomes for the entire cohort (training and validation sets combined) stratified by risk score. A, OS; B, DFS.

    Outcomes for the entire cohort (training and validation sets combined) stratified by risk score. A, OS; B, DFS.

PII: S1083-8791(07)00457-0

doi: 10.1016/j.bbmt.2007.07.016

Biology of Blood and Marrow Transplantation
Volume 14, Issue 1 , Pages 28-35 , January 2008